First Trust Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Sell
48,407
-140,878
-74% -$3.96M ﹤0.01% 2137
2026
Q1
$5.4M Buy
189,285
+71,527
+61% +$2.44M ﹤0.01% 1387
2025
Q4
$4.66M Sell
117,758
-17,362
-13% -$636K ﹤0.01% 1444
2025
Q3
$4.76M Buy
135,120
+2,278
+2% +$78.5K ﹤0.01% 1397
2025
Q2
$4.35M Buy
+132,842
New +$4.32M ﹤0.01% 1427
2024
Q2
Sell
-17,080
Closed -$520K 2316
2024
Q1
$520K Sell
17,080
-8,901
-34% -$298K ﹤0.01% 2135
2023
Q4
$927K Sell
25,981
-26,813
-51% -$997K ﹤0.01% 1986
2023
Q3
$2.31M Buy
52,794
+45,434
+617% +$2.22M ﹤0.01% 1624
2023
Q2
$363K Sell
7,360
-17,339
-70% -$799K ﹤0.01% 2210
2023
Q1
$1.02M Buy
24,699
+17,274
+233% +$717K ﹤0.01% 1955
2022
Q4
$330K Buy
7,425
+500
+7% +$20.9K ﹤0.01% 2295
2022
Q3
$271K Sell
6,925
-26,434
-79% -$1.21M ﹤0.01% 2347
2022
Q2
$1.36M Buy
33,359
+12,629
+61% +$598K ﹤0.01% 1866
2022
Q1
$1.36M Sell
20,730
-2,576
-11% -$167K ﹤0.01% 1935
2021
Q4
$1.62M Sell
23,306
-11,357
-33% -$826K ﹤0.01% 1867
2021
Q3
$2.41M Buy
34,663
+7,661
+28% +$590K ﹤0.01% 1696
2021
Q2
$2.14M Sell
27,002
-1,637
-6% -$119K ﹤0.01% 1779
2021
Q1
$1.88M Buy
28,639
+21,840
+321% +$1.35M ﹤0.01% 1745
2020
Q4
$379K Sell
6,799
-34,188
-83% -$1.48M ﹤0.01% 2180
2020
Q3
$1.64M Sell
40,987
-12,591
-24% -$534K ﹤0.01% 1474
2020
Q2
$2.41M Buy
53,578
+10,907
+26% +$475K ﹤0.01% 1293
2020
Q1
$1.43M Buy
42,671
+29,862
+233% +$1.07M ﹤0.01% 1444
2019
Q4
$416K Sell
12,809
-24,994
-66% -$711K ﹤0.01% 2180
2019
Q3
$943K Buy
+37,803
New +$1.08M ﹤0.01% 1897
2019
Q1
Sell
-13,874
Closed -$425K 2408
2018
Q4
$425K Buy
+13,874
New +$432K ﹤0.01% 2175
2018
Q1
Sell
-51,098
Closed -$932K 2302
2017
Q4
$932K Buy
+51,098
New +$1.01M ﹤0.01% 1878

Other funds holding ATRC

First Trust Advisors's ATRC Position: Q2 2026 in Review

First Trust Advisors reduced its AtriCure (ATRC) stake by 74% in Q2 2026, selling an estimated $3.96M and leaving 48,407 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

First Trust Advisors first reported a position in ATRC in Q4 2017 and has held it in 26 quarters since. The position peaked at $5.4M in Q1 2026. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • First Trust Advisors held 48,407 shares of AtriCure worth $1.35M as of Q2 2026.
  • First Trust Advisors sold 140,878 AtriCure shares in Q2 2026, an estimated $3.96M.
  • AtriCure made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2137 holding.
  • First Trust Advisors first reported a position in AtriCure in Q4 2017 and has held it in 26 quarters since.
  • First Trust Advisors's AtriCure position peaked at $5.4M in Q1 2026.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.